Abrahmsen Lars B.
SEC CIK 1789039 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | SVP, CSO | 43.7K | — | $368.8K | 5 | 2021-09-20 | 2022-03-10 |
Most active insiders at APRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duey Marc | Dir | $25.1K | — |
| 2 | Gilad Oren | Pres, CEO, Dir | $25.0K | — |
| 3 | Hamill John P. | CFO, SrVP, Prin Fin, Acct Ofcr | $10.9K | — |
| 4 | Pamukcu Rifat | Dir | — | — |
| 5 | Gruia Gabriela | Dir | — | — |
| 6 | Seizinger Bernd R. | Dir | — | — |
| 7 | Grissinger Michael | Dir | — | — |
| 8 | Peters Richard | Dir | — | — |
| 9 | BIZZARI JEAN-PIERRE | Dir | — | — |
| 10 | HENNEMAN JOHN B III | Dir | — | — |
Abrahmsen Lars B. made no open-market trades at APRE in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-14 | 2022-03-10 | APRE | Aprea Therapeutics, Inc. | Abrahmsen Lars B. | SVP, CSO | A - Grant | $0.00 | +24.7K | 43.7K | +130% | $0 |
| D | 2021-10-05 | 2021-10-01 | APRE | Aprea Therapeutics, Inc. | Abrahmsen Lars B. | SVP, CSO | S - Sale+OE | $4.89 | -50.0K | 19.0K | -72% | -$244.5K |
| D | 2021-10-05 | 2021-10-01 | APRE | Aprea Therapeutics, Inc. | Abrahmsen Lars B. | SVP, CSO | M - OptEx | $0.92 | +50.0K | 69.0K | +263% | +$46.0K |
| D | 2021-09-22 | 2021-09-20 | APRE | Aprea Therapeutics, Inc. | Abrahmsen Lars B. | SVP, CSO | S - Sale+OE | $4.97 | -25.0K | 19.0K | -57% | -$124.2K |
| D | 2021-09-22 | 2021-09-20 | APRE | Aprea Therapeutics, Inc. | Abrahmsen Lars B. | SVP, CSO | M - OptEx | $0.92 | +25.0K | 44.0K | +132% | +$23.0K |
Purchase Sale Sale after option exercise All abbreviations